Malignant Pancreatic Neoplasm: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
971 |
4. Check minimum number of eventsNone |
971 |
5. Include endpointsNone |
971 |
6. Filter based on genotype QC (FinnGen only) |
954 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum pancreatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pancreas
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4049 | 2363 | 1645 |
| Only index persons | 3590 | 2126 | 1464 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.05 |
| Only index persons | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 69.61 | 70.03 | 69.18 |
| Only index persons | 69.51 | 69.68 | 69.25 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 954 | 546 | 408 |
| Unadjusted period prevalence (%) | 0.19 | 0.19 | 0.19 |
| Median age at first event (years) | 69.90 | 69.01 | 71.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 971
- Matched controls
- 9710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
4503599627370496.0
307.7
960
*
K86.2
ICD-10 Finland
Cyst of pancreas
53.6
307.7
194
45
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
70.7
307.7
464
124
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
19.0
199.9
166
104
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
21.6
197.9
154
84
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.5
182.8
153
97
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
66.5
174.1
96
16
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
23.6
172.6
128
62
JLC30
NOMESCO Finland
Pancreatoduodenectomy
48.9
145.2
85
19
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
31.0
128.1
85
30
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
29.8
114.8
77
28
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.4
111.0
115
104
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
48.1
107.3
63
14
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
22.4
87.3
65
31
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
14.9
78.3
71
51
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.9
73.8
145
279
WZC30
NOMESCO Finland
Teaching
3.6
68.0
292
1029
UJK02
NOMESCO Finland
ERCP
8.2
66.4
92
122
JLC10
NOMESCO Finland
Distal pancreatectomy
125.6
65.8
70
6
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
14.6
63.5
58
42
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
10.2
59.0
68
71
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
292.3
54.8
55
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
15.2
53.9
48
33
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
52.0
283
1132
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.1
51.0
93
165
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
50.6
457
2387
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
17.3
48.1
40
24
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
45.9
131
341
Z71.8
ICD-10 Finland
Other specified counselling
2.7
45.8
394
1986
K83.0
ICD-10 Finland
Cholangitis
10.5
44.6
50
50
RD211, ,
NOMESCO Finland
4.9
42.7
100
222
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
42.6
416
2212
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
40.7
191
691
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.8
40.7
42
37
K83.1
ICD-10 Finland
Obstruction of bile duct
8.6
38.4
50
61
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.6
36.8
132
402
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
36.8
169
602
R4190
NOMESCO Finland
Nutritional therapy
5.6
36.3
72
138
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
35.6
149
501
K86.1
ICD-10 Finland
Other chronic pancreatitis
12.5
35.2
35
29
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
7.5
34.2
50
70
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.5
30.0
112
349
Z3231
NOMESCO Finland
Registered nurse
2.2
28.9
340
1893
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
11.4
28.6
30
27
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
6.9
28.2
44
66
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.7
28.2
40
54
ZX120
NOMESCO Finland
Intravenous
2.9
28.0
149
572
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
7.0
27.3
42
62
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
26.2
105
342
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
61.8
26.1
30
5
ZYC01
NOMESCO Finland
Remote contact by phone
3.6
25.8
92
278
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
20.7
24.5
36
18
JAH01
NOMESCO Finland
Laparoscopy
3.9
23.6
72
195
JMA10
NOMESCO Finland
Transabdominal total splenectomy
19.1
23.2
35
19
R50.9
ICD-10 Finland
Fever, unspecified
2.4
23.0
185
866
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
8.8
22.9
29
34
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
22.5
173
794
B01AB10
ATC
tinzaparin; parenteral
2.5
21.9
150
651
UJF32
NOMESCO Finland
Coloscopy
2.0
21.0
330
2001
130
Kela drug reimbursment
Malignant tumour
2.6
20.4
133
563
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
49.1
20.2
24
5
A02BC02
ATC
pantoprazole; systemic
2.0
19.8
726
5775
N02AX02
ATC
tramadol; systemic, rectal
1.9
19.6
479
3336
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
19.4
160
754
WX402
NOMESCO Finland
General anaesthesia
2.1
19.2
239
1328
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
15.2
19.0
31
21
K86.8
ICD-10 Finland
Other specified diseases of pancreas
21.3
18.7
27
13
A05AA02
ATC
ursodeoxycholic acid; oral
6.6
18.5
30
47
K86.3
ICD-10 Finland
Pseudocyst of pancreas
18.0
18.3
28
16
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
5.7
18.3
34
61
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.3
18.0
150
709
JN4CD
NOMESCO Finland
Very extensive body CT
3.4
17.9
67
208
B01AB05
ATC
enoxaparin; parenteral
1.8
17.9
376
2479
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.2
17.2
70
229
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
15.9
256
1542
Z25.1
ICD-10 Finland
Need for immunization against influenza
2.9
15.8
75
269
K85.8
ICD-10 Finland
Other acute pancreatitis
13.2
15.7
27
21
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
15.4
252
1524
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
15.0
146
733
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
81.4
14.6
16
*
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.2
14.4
133
654
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
14.2
372
2575
JAH00
NOMESCO Finland
Laparotomy
3.8
14.1
44
121
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
14.0
287
1852
N02BE01
ATC
paracetamol; systemic, rectal
2.5
13.9
893
7981
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.6
13.8
45
128
T90
ICPC
Diabetes non-insulin dependent
1.8
13.4
284
1846
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
5.0
13.4
29
60
K85
ICD-10 Finland
Acute pancreatitis
4.7
13.4
31
68
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
13.4
135
687
R4110
NOMESCO Finland
Physiotherapy
1.7
13.2
301
1997
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
40.7
13.2
16
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
17.0
13.0
20
12
J01MA02
ATC
ciprofloxacin; systemic
1.7
13.0
403
2902
A10AB05
ATC
insulin aspart; parenteral
2.4
12.9
92
404
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
22.9
12.9
18
8
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
12.9
285
1872
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
50.7
12.9
15
*
A10AE04
ATC
insulin glargine; parenteral
2.2
12.6
118
582
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
12.6
130
666
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
9.5
12.5
25
27
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
+∞
12.5
12
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
12.5
302
2031
JN4AD
NOMESCO Finland
Body CT examination
2.1
12.5
129
662
J01MA12
ATC
levofloxacin; systemic
1.8
12.4
209
1267
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
10.7
12.3
23
22
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
12.0
224
1397
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
21.6
12.0
17
8
UJK12
NOMESCO Finland
Peroral cholangioscopy
47.3
11.9
14
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
11.8
51
173
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
11.7
160
906
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
12.7
11.7
20
16
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
11.5
59
221
Z00.0
ICD-10 Finland
General medical examination
1.8
11.3
209
1299
HMAK, ,
NOMESCO Finland
2.1
11.2
118
609
J01DB01
ATC
cefalexin; oral
1.8
11.1
789
6881
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
10.2
11.0
21
21
SPAT1359
SPAT
Use of symptom diary
3.5
10.9
38
113
XX2RW, ,
NOMESCO Finland
5.2
10.8
22
43
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
28.4
10.7
14
5
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
10.6
233
1518
SPAT1252
SPAT
Overall medication plan or its review
2.2
10.6
90
427
A02BC05
ATC
esomeprazole; systemic
1.6
10.6
414
3111
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
10.4
91
436
N02AA05
ATC
oxycodone; systemic
1.7
10.4
206
1302
-1, ,
NOMESCO Finland
1.6
10.4
295
2051
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
32.9
10.3
13
*
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
9.7
10.3
20
21
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
19.0
10.3
15
8
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.2
10.2
27
66
SPAT1131
SPAT
Colonoscopy
2.8
10.1
50
184
L01BC06
ATC
capecitabine; oral
2.7
10.1
55
213
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.2
10.0
89
430
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
9.9
218
1416
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
7.5
9.7
22
30
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
55.6
9.7
11
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.3
9.6
71
317
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.5
263
1812
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.0
9.4
41
140
UJF92
NOMESCO Finland
Capsular endoscopy
3.7
9.4
30
84
UJK42
NOMESCO Finland
Peroral pancreaticoscopy
101.0
9.4
10
*
N30.0
ICD-10 Finland
Acute cystitis
1.8
9.3
161
977
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
9.2
121
673
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
9.2
204
1327
R1250
NOMESCO Finland
Evaluation of functional capability
3.5
9.1
31
91
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
9.1
362
2706
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.9
229
1547
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
9.6
8.8
17
18
K30
ICD-10 Finland
Functional dyspepsia
1.9
8.6
114
636
S15
ICPC
Foreign body in skin
2.2
8.6
76
366
C07AB07
ATC
bisoprolol; oral
1.5
8.6
516
4188
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
11.7
8.6
15
13
SPAT1310
SPAT
Counselling related to known health issue
1.5
8.5
311
2276
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
8.5
180
1156
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
12.9
8.4
14
11
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
8.4
267
1894
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
8.3
184
1193
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
8.3
643
5478
A10BA02
ATC
metformin; oral
1.5
8.3
304
2224
AN2
HP
Balloon angioplasty, including several vessels
2.9
8.2
37
129
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.1
8.2
33
108
D02
ICPC
Abdominal pain epigastric
2.3
8.1
64
294
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.8
8.1
18
38
S18
ICPC
Laceration/cut
1.5
8.1
465
3724
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
8.1
47
188
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
33.6
8.1
10
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
8.1
71
342
ZXE00
NOMESCO Finland
One hour or less
1.5
8.0
366
2799
K59.09
ICD-10 Finland
Constipation, unspecified
2.1
8.0
77
384
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.3
8.0
20
47
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
3.6
7.9
25
70
A04AA02
ATC
granisetron; systemic, transdermal
2.1
7.8
75
373
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.1
7.8
31
101
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.8
116
673
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
45.3
7.7
9
*
TQW80
NOMESCO Finland
Local dermatologic skincare
3.0
7.7
33
112
D76
ICPC
Malignant neoplasm pancreas
12.0
7.6
13
11
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
7.6
187
1245
Z51.0
ICD-10 Finland
Radiotherapy session
3.9
7.6
22
58
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
7.5
255
1826
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
7.5
290
2135
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.0
7.5
33
114
N30.9
ICD-10 Finland
Cystitis, unspecified
2.2
7.4
63
299
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
80.7
7.4
8
*
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
7.3
88
475
JN4BD
NOMESCO Finland
Extensive body CT
1.8
7.3
120
716
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
7.3
7
*
RD210, ,
NOMESCO Finland
3.9
7.3
21
55
R21
ICPC
Throat symptom/complaint
1.7
7.1
152
974
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
7.1
364
2829
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
12.1
7.1
12
10
J45.8
ICD-10 Finland
Mixed asthma
2.8
7.1
35
129
B01AB04
ATC
dalteparin; parenteral
2.3
7.1
55
252
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
1.8
7.1
101
578
R5110, ,
SPAT
2.0
7.0
76
396
EC1VA, ,
NOMESCO Finland
2.8
7.0
35
130
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
4.4
7.0
17
39
A03FA02
ATC
cisapride; oral, rectal
1.9
7.0
81
433
Z49.0
ICD-10 Finland
Preparatory care for dialysis
6.4
7.0
17
27
SPAT1262
SPAT
Handing over of treatment supplies
1.6
6.8
181
1224
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.8
6.8
20
53
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.8
498
4125
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
11.0
6.8
12
11
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.8
180
1217
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
6.8
37
144
IHA10
NOMESCO Finland
Structured mapping of problematic alcohol use
16.8
6.8
10
6
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.5
6.7
22
63
XQ848
NOMESCO Finland
Dermatological photography
2.7
6.7
35
133
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
6.5
6.7
16
25
L04AD01
ATC
ciclosporin; systemic
3.6
6.6
21
59
C07AA05
ATC
propranolol; systemic
1.6
6.6
178
1209
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
10.1
6.5
12
12
SPAT1216
SPAT
Assessment of functional ability
1.6
6.5
168
1128
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
6.5
120
740
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
6.5
61
302
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.4
6.4
22
65
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
6.4
84
467
N03AX16
ATC
[U] pregabalin
1.5
6.4
228
1646
R03BA01
ATC
beclometasone; inhalant
1.7
6.4
128
808
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.1
6.3
25
81
D06
ICPC
Abdominal pain localized other
1.9
6.3
78
426
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.0
6.3
27
92
RJ190, ,
NOMESCO Finland
18.1
6.3
9
5
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.5
6.3
38
156
8240/3-C25.2
ICD-O-3
Neuroendocrine tumor, NOS, of tail of pancreas
+∞
6.3
6
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
6.3
57
279
L17
ICPC
Foot/toe symptom/complaint
1.5
6.2
276
2077
127
Kela drug reimbursment
Transplant complication
3.7
6.2
19
52
R07.0
ICD-10 Finland
Pain in throat
2.2
6.2
53
253
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.6
6.2
20
57
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.1
126
799
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.1
260
1941
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.6
6.1
33
128
Z01.7
ICD-10 Finland
Laboratory examination
1.6
6.1
140
914
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
6.1
87
498
D01
ICPC
Abdominal pain/cramps general
1.7
6.1
103
620
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.3
6.1
44
196
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
8.7
6.1
12
14
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
6.1
98
582
WX004
NOMESCO Finland
Patient-controlled sedation
10.1
6.0
11
11
L04AA06
ATC
mycophenolic acid; systemic
3.3
6.0
22
68
K81.9
ICD-10 Finland
Cholecystitis, unspecified
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
405
189
36.05
307.65
3.1
3.6
37.09
1957.31
u/ml
0.83
372
179
322
369
12.56
273.69
4.4
3.4
73.17
3870.69
u/ml
0.79
289
315
472
1003
8.21
236.91
3.6
4.2
2.85
24.42
ug/l
1.92
393
831
359
851
6.11
152.74
2.9
2.1
0.23
0.21
g/l
6.18
350
796
640
2730
4.94
127.89
4.2
2.5
75.23
90.12
u/l
0.20
624
2492
185
274
8.11
123.40
1.6
1.5
216.70
280.86
ug/g
3.13
137
164
333
973
4.69
106.19
3.9
2.7
6.28
8.56
umol/l
2.01
298
855
800
4599
5.20
95.19
10.2
6.3
10.95
11.72
umol/l
1.10
783
4365
60
19
33.59
93.13
4.2
2.6
1765.17
4356.11
u/l
0.39
60
19
262
797
4.13
76.56
4.8
2.3
244.35
35.70
u/l
1.47
237
670
75
7
115.98
69.95
3.0
2.7
71.50
39.87
pmol/l
—
61
7
667
3893
3.28
65.16
8.0
4.8
34.52
35.11
g/l
2.15
653
3629
708
4280
3.42
65.12
15.9
16.3
1.23
1.28
inr
1.07
301
1212
893
6688
5.17
50.64
13.6
7.7
84.67
78.95
u/l
2.50
878
6250
752
5135
3.06
47.80
6.6
4.8
6.96
6.77
mmol/l
1.46
734
4853
195
765
2.94
35.78
5.1
3.7
1.23
1.23
mmol/l
0.07
186
666
449
2644
2.30
34.67
4.4
3.3
35.11
32.62
u/l
0.58
437
2503
452
2698
2.26
33.45
4.4
3.3
53.40
88.15
e6/l
0.51
383
2119
389
2197
2.29
32.73
6.4
3.9
89.01
88.72
%
0.08
382
2147
418
2488
2.19
30.36
4.0
3.2
0.48
0.49
e6/l
0.03
351
1930
675
4866
2.27
29.90
11.4
9.2
4.44
4.13
e9/l
2.20
618
4271
387
2258
2.19
29.32
5.1
4.2
0.00
0.00
estimate
0.50
217
740
632
4499
2.16
27.99
9.2
6.9
1.21
1.21
mmol/l
0.11
534
3822
47
79
6.20
27.06
1.7
1.4
—
—
—
0
0
576
4017
2.07
26.17
3.3
2.6
—
—
—
0
0
238
1185
2.34
26.04
6.7
5.6
1.00
1.03
mmol/l
1.04
231
1085
332
1902
2.13
25.65
3.4
2.6
5.27
5.70
e6/l
0.27
308
1731
854
7029
2.78
24.96
31.0
18.8
14.90
15.33
%
1.64
849
6907
264
1404
2.21
24.48
2.4
1.9
30.18
29.61
s
0.99
259
1360
271
1469
2.17
23.87
3.6
3.3
0.81
0.81
mmol/l
0.80
258
1372
574
4128
1.96
22.39
8.1
6.0
1.21
1.21
mmol/l
1.08
558
3739
50
109
4.78
21.69
1.6
1.3
0.56
0.63
nmol/l
1.04
45
102
148
649
2.51
21.15
3.1
3.0
10.51
10.63
g/l
0.12
131
592
565
4117
1.89
20.34
5.8
5.3
0.00
0.00
estimate
-0.00
221
771
564
4109
1.89
20.30
4.7
3.9
0.00
0.00
estimate
0.75
229
834
568
4165
1.88
19.84
4.7
3.9
0.00
0.00
estimate
-0.00
219
754
73
228
3.38
19.37
1.2
1.2
—
—
—
0
0
234
1287
2.08
19.33
3.4
2.5
2.32
2.31
g/l
0.20
221
1191
493
3506
1.83
18.52
2.9
2.2
79.70
78.73
nmol/l
0.32
469
3066
63
184
3.59
18.52
5.0
4.5
2.99
2.65
mmol/l
0.37
49
126
222
1221
2.06
18.23
3.6
2.5
22.93
22.45
%
0.16
206
1038
545
4011
1.82
18.13
7.2
6.1
26.55
27.12
%
0.53
523
3748
710
5684
1.93
17.88
5.6
4.7
44.00
3015.99
e6/l
—
6
94
243
1396
1.99
17.60
3.4
2.5
12.41
12.70
umol/l
0.22
232
1294
448
3136
1.80
17.38
4.9
4.2
—
—
—
0
0
534
3952
1.78
16.99
6.9
5.8
58.44
57.71
%
0.67
515
3697
245
1432
1.95
16.78
3.7
3.0
2.20
2.18
e6/l
0.02
151
811
75
261
3.03
16.63
2.2
1.6
—
—
—
0
0
472
3444
1.72
15.14
4.2
3.8
38.57
49.16
ng/l
0.28
358
2578
913
8192
2.92
15.06
26.9
15.6
28.77
25.16
mg/l
2.26
811
6549
123
580
2.28
14.74
8.0
8.9
94.73
94.03
%
0.77
123
574
883
7860
2.36
13.72
26.0
14.7
76.14
76.48
ml/min/173m2
0.19
830
6490
44
126
3.61
13.34
1.7
2.0
32.00
32.32
pg
0.18
44
126
150
797
2.04
13.22
8.2
7.3
9.57
10.07
mmol/l
0.41
141
760
398
2850
1.67
13.13
3.4
3.2
6.59
7.13
mmol/l
1.80
349
2356
172
964
1.95
13.03
4.5
3.4
—
—
—
0
0
240
1516
1.77
12.39
1.8
1.5
2.53
2.55
g/l
0.05
179
878
405
2945
1.64
12.38
4.1
3.8
6.39
8.87
mg/mmol
1.27
283
1814
741
6300
1.74
12.00
5.5
4.3
15.00
13.27
mm/h
1.88
710
5765
629
5147
1.63
11.54
4.6
3.2
70.97
52.57
u/l
2.24
599
4728
453
3440
1.59
11.27
4.2
2.8
129.17
143.81
ug/l
0.83
433
3127
129
690
2.00
11.09
2.9
2.8
66.51
61.98
ml/min/173m2
0.66
66
294
379
2785
1.59
10.68
3.4
3.3
350.68
267.42
mg/l
0.14
276
1755
264
1785
1.66
10.39
3.8
3.2
2.47
2.46
mmol/l
0.88
237
1578
54
208
2.69
9.98
1.8
1.5
—
—
—
0
0
19
21
9.20
9.55
1.1
1.1
—
—
—
0
0
19
21
9.20
9.55
1.1
1.1
—
—
—
0
0
927
8665
2.54
8.87
30.0
18.6
3.97
3.98
mmol/l
0.71
922
8424
404
3109
1.51
8.78
4.1
3.5
2.35
2.36
mmol/l
0.21
381
2705
115
640
1.90
8.77
1.7
1.6
—
—
—
0
0
311
2264
1.55
8.74
2.8
2.2
3.45
3.09
mg/l
1.15
282
1923
53
1149
0.43
8.55
5.2
4.8
33.74
32.66
%
0.27
43
751
45
172
2.69
8.47
6.1
6.2
328.78
213.14
iu/ml
—
9
22
260
1829
1.58
8.45
2.0
1.6
1.47
1.30
mg/l
0.30
199
1437
860
7846
1.84
8.44
7.9
6.3
41.93
40.47
mmol/mol
4.45
837
7197
30
91
3.37
8.40
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
314
2.22
8.13
2.8
2.4
0.22
0.40
u/ml
7.87
41
182
54
231
2.42
8.08
3.2
2.5
3.83
3.66
g/l
0.31
54
220
41
154
2.74
7.99
3.1
3.0
4.61
4.49
e9/l
0.12
41
154
929
8737
2.46
7.95
17.9
11.2
26.86
25.34
u/l
1.55
924
8385
22
56
4.00
7.91
1.0
1.2
—
—
—
0
0
42
161
2.68
7.87
3.7
3.2
57.17
59.06
%
0.50
42
161
39
144
2.78
7.85
1.2
1.3
—
—
—
0
0
309
2297
1.51
7.70
3.7
2.8
1881.39
7273.78
umol/l
2.33
285
1974
132
806
1.74
7.41
2.8
3.1
66.08
66.30
g/l
0.12
124
730
53
238
2.30
7.14
1.3
1.6
—
—
—
0
0
165
1080
1.64
7.13
7.7
7.2
0.86
1.20
mmol/l
0.64
140
854
21
56
3.81
7.11
1.0
1.2
—
—
—
0
0
103
592
1.83
7.09
9.0
8.6
1.22
1.33
%
0.93
103
587
218
1541
1.53
6.76
3.2
2.8
1.20
1.12
e6/l
0.12
122
915
159
1048
1.62
6.67
2.0
1.8
—
—
—
0
0
34
128
2.72
6.63
1.4
1.4
99.40
108.67
u/ml
—
10
22
159
1050
1.61
6.61
2.0
1.9
—
—
—
0
0
209
1471
1.54
6.60
1.9
1.9
—
—
—
0
0
69
357
2.00
6.52
2.4
2.8
2.75
3.02
g/l
1.36
62
319
85
473
1.87
6.49
4.0
2.9
0.07
0.24
e6/l
3.51
85
462
44
191
2.37
6.42
1.4
1.3
—
—
—
0
0
65
331
2.03
6.42
2.6
3.0
0.88
1.40
g/l
0.70
55
289
99
586
1.77
6.19
9.3
8.7
0.67
0.68
%
0.06
99
581
159
1068
1.58
6.14
4.1
4.1
232.68
250.35
u/l
0.74
152
1010
58
291
2.06
5.97
2.8
2.9
0.04
0.03
g/l
0.04
51
268
49
231
2.18
5.92
2.7
2.2
90.16
89.05
%
0.13
49
223
135
881
1.62
5.87
2.4
2.1
163.01
131.41
ug/g
0.63
111
689
42
191
2.25
5.55
3.1
2.5
15.95
15.85
%
0.04
23
97
710
6372
1.43
5.54
4.5
4.0
15.12
14.96
pmol/l
0.84
668
5707
261
1982
1.43
5.53
1.8
1.7
457.06
18398427.99
pmol/l
1.56
218
1598
358
2877
1.39
5.47
2.8
3.0
1269.44
1328.04
ng/l
0.11
322
2454
32
130
2.51
5.41
1.2
1.2
299.96
317.44
u/ml
0.09
23
72
69
384
1.86
5.30
2.4
2.7
3.51
3.63
g/l
0.40
62
347
33
138
2.44
5.26
1.1
1.2
—
—
—
0
0
69
385
1.85
5.26
2.4
2.7
7.42
7.44
g/l
0.03
62
347
69
385
1.85
5.26
2.4
2.7
—
—
—
0
0
21
69
3.09
5.24
1.5
1.2
—
—
—
0
0
59
316
1.92
5.09
2.7
4.2
1.55
1.88
ratio
0.20
16
22
936
8984
2.16
4.98
37.9
23.4
39.61
39.70
%
0.23
909
8321
936
8990
2.14
4.87
38.3
23.3
4.36
4.43
e12/l
4.40
927
8711
338
2733
1.36
4.84
2.4
2.2
136.15
228.41
u/l
2.36
327
2568
59
322
1.89
4.83
2.8
4.2
28.45
62.20
mg/l
1.10
49
264
59
322
1.89
4.83
2.8
4.2
35.54
75.86
mg/l
1.32
49
262
936
8993
2.13
4.81
38.6
23.4
130.40
133.85
g/l
10.24
931
8836
28
114
2.50
4.74
1.2
1.1
40.57
117.33
iu/ml
—
7
18
84
513
1.70
4.73
1.6
1.5
—
—
—
0
0
935
8988
2.09
4.67
38.4
23.3
253.47
245.98
e9/l
2.51
928
8735
226
1719
1.41
4.66
1.3
1.2
0.99
1.72
u/ml
1.16
94
434
283
2249
1.36
4.46
1.7
1.5
22.03
20.64
nmol/l
0.81
261
1878
36
169
2.17
4.45
2.3
1.9
5.19
4.70
mmol/24h
0.36
29
146
493
4265
1.32
4.31
2.6
2.5
—
—
—
0
0
268
2122
1.36
4.30
3.2
2.4
—
—
—
0
0
15
39
3.89
4.20
5.7
4.2
—
—
—
0
0
226
1747
1.38
4.20
4.0
4.0
279.77
375.46
ng/l
0.27
182
1444
55
308
1.83
4.19
2.6
2.8
37.45
37.38
g/l
0.03
48
270
151
1091
1.45
4.10
2.3
2.6
1.83
1.85
%
0.09
145
974
72
442
1.68
4.01
3.0
3.1
4.49
4.47
pmol/l
0.03
65
383
19
70
2.75
3.94
1.4
1.7
—
—
—
0
0
19
70
2.75
3.94
1.2
1.5
0.45
0.36
nmol/l
0.14
13
52
16
54
3.00
3.86
1.4
1.6
—
—
—
0
0
27
122
2.25
3.70
9.8
5.6
11.42
12.18
mg/l
0.42
27
112
864
8200
1.49
3.68
5.7
4.9
6.24
6.04
mmol/l
3.62
826
7360
68
422
1.66
3.65
1.9
3.6
28.19
75.82
u/ml
2.49
63
407
288
2355
1.32
3.64
1.7
1.7
1.42
1.36
mmol/l
0.53
247
1950
815
7661
1.40
3.59
5.3
4.8
1.90
2.16
mu/l
0.94
773
6908
34
171
2.02
3.57
1.6
1.7
50.71
42.22
nmol/l
0.32
34
160
14
46
3.07
3.54
1.6
1.5
0.85
1.05
nmol/l
0.59
14
34
434
3776
1.27
3.33
2.4
2.1
92.30
94.95
pmol/l
0.63
265
1890
26
122
2.16
3.28
2.0
1.7
—
—
—
0
0
15
54
2.81
3.26
1.4
1.6
—
—
—
0
0
22
97
2.30
3.21
2.1
1.8
—
—
—
0
0
60
375
1.64
3.17
2.1
1.9
38.35
39.28
u/l
0.13
55
328
34
181
1.91
3.08
1.4
1.3
40.13
30.05
iu/l
0.78
27
158
28
139
2.04
3.08
1.2
1.1
—
—
—
0
0
103
734
1.45
3.03
6.0
3.7
84.47
91.24
ng/l
0.37
86
631
49
294
1.70
3.02
2.2
1.6
116.67
100.00
titre
—
6
9
19
81
2.37
3.00
1.4
1.3
33.55
28.88
%
0.21
13
51
81
553
1.51
2.95
1.7
1.7
—
—
—
0
0
9
22
4.12
2.88
1.4
1.7
1782.89
91.68
nmol/24h
—
9
22
20
90
2.25
2.81
1.9
2.2
—
—
—
0
0
46
278
1.69
2.79
2.8
3.0
0.00
0.00
g/l
-0.00
40
255
51
317
1.64
2.78
2.3
3.0
—
—
—
0
0
5
6
8.37
2.75
2.0
1.7
—
—
—
0
0
56
361
1.58
2.65
2.5
2.8
9.35
10.42
g/l
1.22
49
322
12
43
2.81
2.65
1.2
1.2
—
—
—
0
0
175
1392
1.31
2.64
1.4
1.3
30.22
36.90
iu/ml
0.40
57
447
42
252
1.70
2.62
1.5
1.5
0.23
0.23
g/l
0.08
42
241
7
15
4.69
2.60
9.1
7.8
4.70
5.77
mmol/l
—
7
15
11
36
3.08
2.57
1.0
1.0
—
—
—
0
0
12
44
2.75
2.55
2.2
2.1
—
—
—
0
0
6
11
5.48
2.54
1.0
1.5
—
—
—
0
0
77
538
1.47
2.53
2.1
2.2
13.47
12.48
nmol/l
0.44
72
470
84
1151
0.70
2.46
14.2
7.6
—
—
—
0
0
114
862
1.37
2.42
6.2
3.5
1.48
2.03
mmol/l
0.87
102
703
15
65
2.33
2.32
1.0
1.0
283.27
293.80
mg/l
0.19
15
54
28
155
1.83
2.32
1.9
1.8
—
—
—
0
0
35
208
1.71
2.29
1.7
1.7
—
—
—
0
0
8
23
3.50
2.27
1.1
1.1
92.52
139.16
iu/ml
—
8
23
5
9
5.58
2.21
3.8
5.7
—
—
—
0
0
15
67
2.26
2.18
1.4
1.5
—
—
—
0
0
41
260
1.60
2.12
1.5
1.5
1.11
1.16
g/l
0.40
41
248
21
110
1.93
2.06
1.5
1.6
—
—
—
0
0
35
215
1.65
2.06
1.7
1.7
—
—
—
0
0
7
20
3.52
2.05
2.1
1.5
—
—
—
0
0
6
15
4.02
2.04
2.0
1.2
—
—
—
0
0
28
163
1.74
2.00
1.8
1.5
—
—
—
0
0
22
119
1.87
1.98
1.7
1.9
91.30
89.37
%
1.64
22
119
866
8371
1.32
1.95
5.6
5.4
2.50
2.68
mmol/l
7.22
822
7607
25
142
1.78
1.94
1.3
1.5
—
—
—
0
0
7
174
0.40
1.91
1.3
1.3
—
—
—
0
0
12
52
2.32
1.88
1.8
1.5
80.08
80.98
umol/l
0.06
12
52
52
362
1.46
1.81
1.0
1.0
—
—
—
0
0
64
464
1.41
1.79
1.3
1.2
412.95
250.28
u/ml
0.22
57
417
42
281
1.52
1.77
1.2
1.2
—
—
—
0
0
14
67
2.11
1.76
1.8
1.1
98.00
187.50
titre
—
5
12
101
793
1.31
1.71
1.6
1.7
1.66
1.55
%
0.43
82
658
17
89
1.93
1.70
1.9
1.9
11597.84
6305.38
u/l
—
8
24
27
165
1.65
1.66
5.0
2.0
67.13
61.00
%
0.69
27
165
13
62
2.11
1.66
1.1
1.2
—
—
—
0
0
22
128
1.74
1.61
2.0
1.5
—
—
—
0
0
130
1064
1.26
1.60
1.3
1.4
—
—
—
0
0
8
32
2.51
1.60
1.3
1.1
—
65.20
%
—
0
5
211
1818
1.21
1.59
4.8
4.4
1.02
1.02
kg/l
0.14
17
270
7
26
2.70
1.58
1.3
1.3
—
—
—
0
0
198
1699
1.21
1.56
3.4
3.3
0.76
0.75
ug/l
0.03
134
1192
159
1340
1.22
1.51
1.4
1.3
8.41
13.30
u/ml
0.54
77
467
38
259
1.49
1.50
1.3
1.2
—
—
—
0
0
0
45
0.00
1.50
0.0
2.5
—
—
—
0
0
36
243
1.50
1.49
1.4
1.5
0.44
0.08
iu/ml
—
10
48
34
497
0.67
1.48
1.8
1.8
—
—
—
0
0
9
37
2.45
1.48
2.6
1.8
1.36
6.46
nmol/l
—
9
30
11
52
2.13
1.44
1.3
1.4
—
—
—
0
0
11
52
2.13
1.44
1.3
1.4
—
—
—
0
0
812
7853
1.21
1.39
4.3
4.2
1.34
1.29
mmol/l
1.33
759
7059
13
67
1.95
1.38
1.0
1.2
—
—
—
0
0
37
256
1.46
1.38
1.3
1.6
—
—
—
0
0
10
197
0.50
1.37
1.8
1.6
—
—
—
0
0
28
183
1.55
1.35
1.4
1.4
—
—
—
0
0
28
183
1.55
1.35
1.4
1.4
—
—
—
0
0
21
128
1.65
1.34
1.1
1.1
—
—
—
0
0
37
258
1.45
1.33
1.3
1.2
—
—
—
0
0
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
31
211
1.48
1.26
1.4
1.4
—
—
—
0
0
59
457
1.31
1.16
1.2
1.2
74.28
136.43
iu/ml
1.72
25
174
8
39
2.06
1.15
1.0
1.2
—
—
—
0
0
5
111
0.45
1.13
3.0
4.4
310.00
359.04
umol/l
—
5
99
20
127
1.59
1.12
1.4
1.5
—
—
—
0
0
10
181
0.55
1.09
1.1
1.1
—
—
—
0
0
28
196
1.44
1.03
3.3
2.3
127.77
127.63
g/l
0.01
22
148
11
60
1.84
1.03
2.5
1.5
0.91
0.98
g/l
0.35
11
60
5
109
0.46
1.01
1.0
1.1
—
20.02
—
0
5
17
107
1.60
1.00
1.1
1.3
—
—
—
0
0
31
223
1.40
0.99
2.1
1.7
9898.13
16097.03
e6/l
0.82
23
166
5
23
2.18
0.98
1.2
1.7
15.80
13.63
pmol/l
—
5
16
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
18
116
1.56
0.97
1.4
1.4
52.73
61.80
%
0.41
11
75
839
8197
1.17
0.95
5.0
4.7
4.42
4.60
mmol/l
5.56
793
7492
9
51
1.77
0.94
2.6
2.7
13.78
13.33
%
—
9
51
6
117
0.51
0.94
1.2
1.4
—
—
—
0
0
6
118
0.51
0.94
1.2
1.4
—
—
—
0
0
6
118
0.51
0.94
1.2
1.4
—
—
—
0
0
6
119
0.50
0.94
1.2
1.4
—
—
—
0
0
6
119
0.50
0.94
1.2
1.4
—
—
—
0
0
24
167
1.45
0.92
1.3
1.1
24.16
31.75
u/ml
—
5
15
26
184
1.42
0.92
1.8
1.6
4.02
5.60
iu/l
0.57
11
57
96
816
1.20
0.89
2.5
2.5
5.12
6.47
ug/l
0.64
84
712
17
253
0.67
0.88
1.5
1.7
2.04
2.97
mg/l
0.61
11
201
12
72
1.68
0.85
1.0
1.1
—
—
—
0
0
26
188
1.39
0.83
1.6
1.6
—
—
—
0
0
123
1075
1.17
0.83
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
48
1.67
0.79
1.0
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
1.3
—
24.29
—
0
21
16
107
1.50
0.76
2.4
3.8
—
—
—
0
0
313
2921
1.11
0.76
5.5
5.4
2.41
2.98
ug/l
0.69
283
2600
14
91
1.55
0.75
2.2
2.4
—
—
—
0
0
830
8135
1.14
0.74
4.8
4.7
1.45
1.48
mmol/l
0.77
781
7378
5
26
1.93
0.70
1.2
1.1
—
—
—
0
0
15
101
1.49
0.70
2.2
1.7
—
—
—
0
0
15
101
1.49
0.70
2.2
1.7
—
—
—
0
0
9
59
1.53
0.68
1.6
1.7
—
—
—
0
0
7
119
0.59
0.68
1.1
1.4
—
—
—
0
0
55
458
1.21
0.67
1.9
1.8
1.41
1.53
g/l
0.48
48
397
196
1802
1.11
0.64
2.0
1.8
1353.66
1202.52
nmol/l
1.43
152
1333
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
44
365
1.22
0.57
1.4
1.3
—
—
—
0
0
33
267
1.24
0.54
2.1
1.7
—
—
—
0
0
25
196
1.28
0.53
1.2
1.2
20.17
55.77
e6/l
0.53
18
154
6
41
1.47
0.50
1.2
1.7
—
—
—
0
0
48
416
1.16
0.42
1.5
1.8
—
—
—
0
0
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
3.8
1.6
—
—
—
0
0
15
191
0.78
0.37
1.4
1.4
—
—
—
0
0
10
72
1.39
0.37
1.2
1.2
8.70
12.69
u/l
—
10
64
6
43
1.40
0.35
1.5
2.7
423.67
1213.58
u/ml
—
6
43
15
118
1.28
0.33
1.6
1.4
2341.13
1700.38
e6/l
—
8
81
10
74
1.36
0.32
1.1
1.1
—
—
—
0
0
27
314
0.86
0.30
2.0
1.8
—
—
—
0
0
27
231
1.17
0.30
1.4
1.2
6.38
14.87
u/ml
—
5
10
13
102
1.28
0.30
1.0
1.2
2.33
5.43
u/ml
—
6
47
43
382
1.13
0.30
1.4
1.7
—
—
—
0
0
7
57
1.23
0.29
1.0
1.4
—
50.00
—
0
8
8
63
1.27
0.27
1.1
1.3
14.25
13.78
u/l
—
8
58
9
75
1.20
0.25
3.0
1.9
—
—
—
0
0
13
105
1.24
0.25
1.7
1.4
31661.00
64223.95
e6/l
—
6
56
7
91
0.77
0.22
1.0
1.8
—
—
—
0
0
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
6.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
23.58
—
0
13
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
28
249
1.13
0.21
1.9
2.4
95.89
82.46
ug/min
0.10
18
149
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
76
808
0.94
0.20
2.8
3.0
195.13
209.36
ng/l
0.11
68
745
6
52
1.15
0.19
2.3
3.3
—
—
—
0
0
12
143
0.84
0.18
1.4
1.7
—
—
—
0
0
21
185
1.14
0.18
1.5
1.8
—
—
—
0
0
7
60
1.17
0.18
1.0
1.4
—
275.00
—
0
6
31
341
0.91
0.17
1.9
1.9
—
—
—
0
0
5
67
0.75
0.17
1.0
1.5
—
27.11
—
0
9
5
70
0.71
0.16
1.6
1.1
—
90.88
—
0
8
17
149
1.14
0.15
2.1
1.7
—
—
—
0
0
17
149
1.14
0.15
2.1
1.7
—
—
—
0
0
24
216
1.11
0.15
1.4
1.2
3.13
2.79
u/ml
—
7
23
28
255
1.10
0.15
2.0
1.3
—
—
—
0
0
8
99
0.81
0.13
1.1
1.8
—
—
—
0
0
22
200
1.10
0.12
1.1
1.3
—
—
—
0
0
24
220
1.09
0.12
1.5
1.2
1.66
7.86
u/ml
—
9
34
10
86
1.16
0.11
1.1
1.1
—
—
—
0
0
5
44
1.14
0.10
1.4
1.6
—
—
—
0
0
5
44
1.14
0.10
1.4
1.6
—
—
—
0
0
5
44
1.14
0.10
1.4
1.6
—
—
—
0
0
12
106
1.13
0.10
1.0
1.0
—
—
—
0
0
6
54
1.11
0.09
1.2
1.0
—
—
—
0
0
7
67
1.05
0.08
2.3
1.3
46.89
33.63
u/l
—
7
51
6
72
0.83
0.07
1.0
1.0
25.33
48.83
ng/l
—
6
41
6
72
0.83
0.07
1.0
1.0
211.50
335.28
ng/l
—
6
43
6
73
0.82
0.07
2.0
2.1
—
—
—
0
0
8
90
0.89
0.06
1.5
1.6
—
—
—
0
0
10
90
1.11
0.05
1.0
1.1
122.80
116.20
%
—
10
84
55
537
1.03
0.04
3.3
3.6
1.62
1.86
mmol/l
0.27
35
413
235
2366
0.99
0.03
4.7
4.7
21.92
21.24
%
0.29
118
1218
10
94
1.06
0.01
1.1
1.1
—
—
—
0
0
10
95
1.05
0.00
1.0
1.1
—
—
—
0
0
6
67
0.89
0.00
1.0
1.3
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.7
—
—
—
0
0
8
83
0.96
-0.00
1.1
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.6
1.6
—
—
—
0
0
8
83
0.96
-0.00
1.1
1.6
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.50
—
0
6
8
80
1.00
-0.00
1.0
1.0
—
—
—
0
0
8
83
0.96
-0.00
1.1
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PANCREAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PANCREAS | 2.49 [2.03, 3.05] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.372 |
During the follow-up period (1.1.1998 — 31.12.2019), 488 out of 1662 females with CD2_BENIGN_PANCREAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PANCREAS | 3.362 [2.54, 4.46] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 427 out of 1130 males with CD2_BENIGN_PANCREAS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PANCREAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.271% | 0.774% |
| 5 | 1.715% | 4.164% |
| 10 | 4.112% | 9.607% |
| 15 | 7.39% | 17.252% |
| 20 | 12.905% | 28.711% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PANCREAS – Benign neoplasm: Pancreas
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data